GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raia Drogasil SA (BSP:RADL3) » Definitions » Gross Profit

Raia Drogasil (BSP:RADL3) Gross Profit : R$10,545 Mil (TTM As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Raia Drogasil Gross Profit?

Raia Drogasil's gross profit for the three months ended in Mar. 2024 was R$2,659 Mil. Raia Drogasil's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was R$10,545 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Raia Drogasil's gross profit for the three months ended in Mar. 2024 was R$2,659 Mil. Raia Drogasil's Revenue for the three months ended in Mar. 2024 was R$9,100 Mil. Therefore, Raia Drogasil's Gross Margin % for the quarter that ended in Mar. 2024 was 29.22%.

Raia Drogasil had a gross margin of 29.22% for the quarter that ended in Mar. 2024 => Competition eroding margins

During the past 13 years, the highest Gross Margin % of Raia Drogasil was 31.13%. The lowest was 29.16%. And the median was 30.04%.


Raia Drogasil Gross Profit Historical Data

The historical data trend for Raia Drogasil's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raia Drogasil Gross Profit Chart

Raia Drogasil Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,198.36 5,891.13 7,206.17 8,809.47 10,207.36

Raia Drogasil Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,321.74 2,610.07 2,590.15 2,685.41 2,659.26

Competitive Comparison of Raia Drogasil's Gross Profit

For the Pharmaceutical Retailers subindustry, Raia Drogasil's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raia Drogasil's Gross Profit Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's Gross Profit distribution charts can be found below:

* The bar in red indicates where Raia Drogasil's Gross Profit falls into.



Raia Drogasil Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Raia Drogasil's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=33973.79 - 23766.426
=10,207

Raia Drogasil's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=9100.494 - 6441.23
=2,659

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$10,545 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Raia Drogasil's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=2,659 / 9100.494
=29.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Raia Drogasil  (BSP:RADL3) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Raia Drogasil had a gross margin of 29.22% for the quarter that ended in Mar. 2024 => Competition eroding margins


Raia Drogasil Gross Profit Related Terms

Thank you for viewing the detailed overview of Raia Drogasil's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Raia Drogasil (BSP:RADL3) Business Description

Traded in Other Exchanges
Address
Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-9000
Raia Drogasil SA is a large retail drug store operator in Brazil. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, cosmetics, household items, and personal care products. The company also acts as a pharmacy benefit manager, performing medical purchases with prenegotiated discounts. The majority of Raia Drogasil's revenue is generated through branded drug sales, while the bulk of the remaining revenue stems from perfumery, over-the-counter drugs, and generic drugs. The company owns a variety of stakes in operational subsidiaries.

Raia Drogasil (BSP:RADL3) Headlines

No Headlines